Literature DB >> 21161390

CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.

Shaoqiong Duan1, Guoyu Zhang, Qunying Han, Zhu Li, Zhengwen Liu, Jinghong Chen, Yi Lv, Na Li, Yawen Wang, Man Li, Sai Lou, Mingbo Yang, Qianqian Zhu, Fanfan Xing.   

Abstract

Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) plays a pivotal role in regulating T cell activation, which is believably critical for the outcome of hepatitis B virus (HBV) infection. The expression and function of CTLA-4 may be affected by gene polymorphisms. This study investigated the influence of CTLA-4 polymorphisms on disease susceptibility in Chinese Han patients with chronic HBV infection. CTLA-4 +49A/G and -318C/T polymorphisms were evaluated by DNA amplification with polymerase chain reaction followed by the restriction fragment length polymorphism analysis. The patients with chronic HBV infection had higher frequencies of genotype AA and allele A of CTLA-4 +49A/G polymorphism. The haplotype +49A-318C was significantly over-represented (P < 0.001) and haplotype +49G-318C under-represented (P = 0.006) in the patients. The +49GG genotype was more frequent (P = 0.009) and +49A allele was less frequent in patients with lower ALT levels (P = 0.012) in HBeAg positive chronic hepatitis B. It is indicated that CTLA-4 +49A/G polymorphism alone and in a haplotype with -318C allele may confer susceptibility to chronic HBV infection in Chinese Han patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161390     DOI: 10.1007/s11033-010-0660-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  42 in total

1.  Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population.

Authors:  L Bouqbis; H Izaabel; O Akhayat; A Pérez-Lezaun; F Calafell; J Bertranpetit; D Comas
Journal:  Genes Immun       Date:  2003-03       Impact factor: 2.676

2.  The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.

Authors:  C-O Jonson; M Hedman; M Karlsson Faresjö; R Casas; J Ilonen; J Ludvigsson; O Vaarala
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease.

Authors:  Dimitry A Chistiakov; Kirill V Savost'anov; Rustam I Turakulov; Ilya A Efremov; Lev M Demurov
Journal:  Clin Immunol       Date:  2005-11-16       Impact factor: 3.969

Review 4.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

5.  Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Authors:  Dongping Xu; Junliang Fu; Lei Jin; Hui Zhang; Chunbao Zhou; Zhengsheng Zou; Jing-Min Zhao; Bin Zhang; Ming Shi; Xilai Ding; Zirong Tang; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 6.  Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies.

Authors:  Alan Korman; Michael Yellin; Tibor Keler
Journal:  Curr Opin Investig Drugs       Date:  2005-06

7.  +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.

Authors:  Xing Gu; Peng Qi; Feiguo Zhou; Qiang Ji; Hao Wang; Tonghai Dou; Yunpeng Zhao; Chunfang Gao
Journal:  Hum Immunol       Date:  2010-01       Impact factor: 2.850

8.  Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population.

Authors:  Lie-Ying Fan; Xiao-Qing Tu; Qu-Bo Cheng; Ye Zhu; Ralph Feltens; Thomas Pfeiffer; Ren-Qian Zhong
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

9.  Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection.

Authors:  Leland J Yee; Kevin A Perez; Jianming Tang; Dirk J van Leeuwen; Richard A Kaslow
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

10.  CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus.

Authors:  Francisco Aguilar; Belén Torres; Julio Sánchez-Román; Antonio Núñez-Roldán; María Francisca González-Escribano
Journal:  Hum Immunol       Date:  2003-10       Impact factor: 2.850

View more
  15 in total

1.  Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.

Authors:  Mahdiyar Iravani Saadi; Ramin Yaghobi; Mohammad Hossein Karimi; Bita Geramizadeh; Mani Ramzi; Maryam Zakerinia
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

2.  -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies.

Authors:  Na Wang; Rongmiao Zhou; Chunmei Wang; Xiaoqing Guo; Zhifeng Chen; Shan Yang; Yan Li
Journal:  Mol Biol Rep       Date:  2011-06-17       Impact factor: 2.316

3.  Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection.

Authors:  Qunying Han; Shaoqiong Duan; Guoyu Zhang; Zhu Li; Na Li; Qianqian Zhu; Yi Lv; Jinghong Chen; Zhengwen Liu
Journal:  Inflamm Res       Date:  2011-08-17       Impact factor: 4.575

4.  Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection.

Authors:  Qunying Han; Na Li; Qianqian Zhu; Zhu Li; Guoyu Zhang; Jinghong Chen; Yi Lv; Yawen Wang; Zhengwen Liu; Chunqiu Hao
Journal:  Clin Exp Med       Date:  2012-09-25       Impact factor: 3.984

Review 5.  Association of genetic polymorphisms with osteosarcoma risk: a meta-analysis.

Authors:  Zhenyu Bian; Qifang He; Xuepeng Wang; Maoqiang Li; Liulong Zhu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  Association of genetic variation of sodium taurocholate cotransporting polypeptide with chronic hepatitis B virus infection.

Authors:  Na Li; Pingping Zhang; Cuiling Yang; Qianqian Zhu; Zhu Li; Fang Li; Qunying Han; Yawen Wang; Yi Lv; Ping Wei; Zhengwen Liu
Journal:  Genet Test Mol Biomarkers       Date:  2014-04-15

7.  CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients.

Authors:  Yifeng Guo; Fang Guo; Chongyang Wei; Jianxin Qiu; Yong Liu; Yu Fang; Junwei Gao
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

8.  Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations.

Authors:  Fabrício C Dias; Tiago da S Medina; Celso T Mendes-Junior; Roberto O Dantas; Cristina W Pissetti; Virmondes Rodrigues Junior; Renata Dellalibera-Joviliano; José A Marin-Neto; Fredy R S Gutierrez; Philippe Moreau; João S Silva; Eduardo A Donadi
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

9.  The Cytotoxic T Lymphocyte Antigen-4 +49A/G Single Nucleotide Polymorphism Association With Visceral Leishmaniasis.

Authors:  Mehrdad Hajilooi; Pegah Lotfi; Farhad Seif; Ahad Bazmani; Mohammad Momeni; Ali Ravary; Mohammad Kazemi Arababadi; Ali Reza Khalilian
Journal:  Jundishapur J Microbiol       Date:  2014-10-01       Impact factor: 0.747

10.  Association between TNFAIP3 nonsynonymous single-nucleotide polymorphism rs2230926 and chronic hepatitis B virus infection in a Chinese Han population.

Authors:  Pingping Zhang; Na Li; Qianqian Zhu; Fang Li; Cuiling Yang; Xiaoyan Zeng; Yi Lv; Zhihua Zhou; Qunying Han; Zhengwen Liu
Journal:  Virol J       Date:  2015-02-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.